CeNeRx BioPharma's Series B - II Round

CeNeRx BioPharma raised a round of funding on June 19, 2009.

CeNeRx is a specialty biopharmaceutical company developing and commercializing treatments for diseases of the central nervous system (CNS). CeNeRx is developing a balanced portfolio that includes clin…

Articles about CeNeRx BioPharma's Series B - II Round: